aMe5 (R), n=17 cell(s)

Main group: Visual Projection Neurons; Neurotransmitter consensus prediction: ACh

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 1.3 0.4 35.8 18.9 26.8 301.6 111.0 21.5 0.6 - 517.9
1 - - 0.6 0.5 0.3 22.6 11.5 1.1 - - 36.7
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - - -
Pre - - - - - - - -
  AME
0 38.5
1 33.1
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 65.3
1 114.6

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses: 8805

Number of pre synapses: 624

Number of output connections: 1358

Coverage factor: 1.5

Columnar completeness: 0.85

Area completeness: 0.91

Cell size (columns): 55

Lobula

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Lobula Plate

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#aMe5 (R) % % cumu.
0 Mi15 (R) ACh 2,137 125.7 22.2% 22.2%
1 Tm39 (R) ACh 528 31.1 5.5% 27.7%
2 MeTu3c (R) ACh 514 30.2 5.3% 33.0%
3 Mi10 (R) ACh 441 25.9 4.6% 37.6%
4 aMe5 (R) ACh 348 20.5 3.6% 41.2%
5 Mi9 (R) Glu 310 18.2 3.2% 44.5%
6 Dm8b (R) Glu 262 15.4 2.7% 47.2%
7 MeLo4 (R) ACh 260 15.3 2.7% 49.9%
8 Tm29 (R) Glu 259 15.2 2.7% 52.6%
9 MeTu3b (R) ACh 253 14.9 2.6% 55.2%
10 Tm26 (R) ACh 245 14.4 2.5% 57.8%
11 Tm5c (R) Glu 237 13.9 2.5% 60.2%
12 Cm31b (R) GABA 235 13.8 2.4% 62.7%
13 Tm5b (R) ACh 229 13.5 2.4% 65.1%
14 Tm12 (R) ACh 144 8.5 1.5% 66.5%
15 MeVPMe11 (L) Glu 107 6.3 1.1% 67.7%
16 Cm34 (R) Glu 106 6.2 1.1% 68.8%
17 aMe6b (R) ACh 92 5.4 1.0% 69.7%
18 MeVP3 (R) ACh 90 5.3 0.9% 70.7%
19 aMe2 (R) Glu 84 4.9 0.9% 71.5%
20 aMe10 (L) ACh 83 4.9 0.9% 72.4%
21 Cm11d (R) ACh 82 4.8 0.9% 73.2%
22 HBeyelet (R) His 80 4.7 0.8% 74.1%
23 Cm31a (R) GABA 74 4.4 0.8% 74.8%
24 R8y (R) His 74 4.4 0.8% 75.6%
25 Dm-DRA1 (R) Glu 70 4.1 0.7% 76.3%
26 Cm7 (R) Glu 69 4.1 0.7% 77.1%
27 Dm2 (R) ACh 59 3.5 0.6% 77.7%
28 Mi16 (R) GABA 58 3.4 0.6% 78.3%
29 TmY21 (R) ACh 58 3.4 0.6% 78.9%
30 aMe10 (R) ACh 57 3.4 0.6% 79.5%
31 Mi4 (R) GABA 57 3.4 0.6% 80.1%
32 Dm9 (R) Glu 54 3.2 0.6% 80.6%
33 MeVP12 (R) ACh 54 3.2 0.6% 81.2%
34 Cm26 (R) Glu 53 3.1 0.6% 81.7%
35 aMe6c (R) Glu 52 3.1 0.5% 82.3%
36 aMe30 (R) Glu 48 2.8 0.5% 82.8%
37 Cm20 (R) GABA 47 2.8 0.5% 83.3%
38 MeLo3b (R) ACh 46 2.7 0.5% 83.7%
39 Tm5a (R) ACh 44 2.6 0.5% 84.2%
40 MeVPMe6 (L) Glu 42 2.5 0.4% 84.6%
41 Tm3 (R) ACh 38 2.2 0.4% 85.0%
42 aMe12 (R) ACh 36 2.1 0.4% 85.4%
43 LA_ME_unclear (R) ACh 33 1.9 0.3% 85.7%
44 Cm2 (R) ACh 32 1.9 0.3% 86.1%
45 MeVC2 (L) ACh 32 1.9 0.3% 86.4%
46 Cm1 (R) ACh 30 1.8 0.3% 86.7%
47 MeVPMe3 (L) Glu 30 1.8 0.3% 87.0%
48 Cm4 (R) Glu 29 1.7 0.3% 87.3%
49 Cm11b (R) ACh 26 1.5 0.3% 87.6%
50 Cm22 (R) GABA 26 1.5 0.3% 87.9%
51 Cm6 (R) GABA 26 1.5 0.3% 88.1%
52 Dm8a (R) Glu 26 1.5 0.3% 88.4%
53 OA-AL2i3 (R) OA 26 1.5 0.3% 88.7%
54 Y14 (R) Glu 26 1.5 0.3% 89.0%
55 aMe22 (R) Glu 25 1.5 0.3% 89.2%
56 L5 (R) ACh 25 1.5 0.3% 89.5%
57 R8p (R) His 25 1.5 0.3% 89.7%
58 MeLo1 (R) ACh 24 1.4 0.2% 90.0%
59 MeVPMe7 (L) Glu 24 1.4 0.2% 90.2%
60 Cm17 (R) GABA 22 1.3 0.2% 90.5%
61 LT58 (R) Glu 22 1.3 0.2% 90.7%
62 MeTu3a (R) ACh 22 1.3 0.2% 90.9%
63 MeVC10 (L) ACh 21 1.2 0.2% 91.1%
64 Tm30 (R) GABA 21 1.2 0.2% 91.4%
65 Cm21 (R) GABA 20 1.2 0.2% 91.6%
66 R7p (R) His 20 1.2 0.2% 91.8%
67 Cm11a (R) ACh 19 1.1 0.2% 92.0%
68 Dm-DRA2 (R) Glu 18 1.1 0.2% 92.2%
69 MeVP7 (R) ACh 18 1.1 0.2% 92.3%
70 Tm20 (R) ACh 18 1.1 0.2% 92.5%

Outputs

  instance NT total connections connections /#aMe5 (R) % % cumu.
0 aMe4 (R) ACh 496 29.2 11.9% 11.9%
1 aMe5 (R) ACh 348 20.5 8.3% 20.2%
2 MeVPaMe2 (L) Glu 273 16.1 6.5% 26.8%
3 aMe10 (R) ACh 245 14.4 5.9% 32.7%
4 MeVPaMe2 (R) Glu 212 12.5 5.1% 37.7%
5 aMe2 (R) Glu 190 11.2 4.6% 42.3%
6 aMe1 (R) GABA 185 10.9 4.4% 46.7%
7 MeVPMe12 (R) ACh 172 10.1 4.1% 50.9%
8 Tm30 (R) GABA 126 7.4 3.0% 53.9%
9 MeLo3b (R) ACh 109 6.4 2.6% 56.5%
10 aMe6b (R) ACh 99 5.8 2.4% 58.9%
11 aMe23 (R) unclear 75 4.4 1.8% 60.7%
12 MeVP12 (R) ACh 74 4.4 1.8% 62.4%
13 MeVP14 (R) ACh 73 4.3 1.8% 64.2%
14 aMe24 (R) unclear 63 3.7 1.5% 65.7%
15 MeVPMe3 (R) Glu 62 3.6 1.5% 67.2%
16 Cm21 (R) GABA 57 3.4 1.4% 68.6%
17 aMe15 (R) unclear 51 3.0 1.2% 69.8%
18 Cm35 (R) GABA 51 3.0 1.2% 71.0%
19 Cm8 (R) GABA 48 2.8 1.2% 72.2%
20 Tm31 (R) Glu 44 2.6 1.1% 73.2%
21 MeVPMe4 (R) Glu 40 2.4 1.0% 74.2%
22 Cm7 (R) Glu 39 2.3 0.9% 75.1%
23 Tm38 (R) ACh 39 2.3 0.9% 76.0%
24 aMe17b (R) GABA 36 2.1 0.9% 76.9%
25 Cm15 (R) GABA 32 1.9 0.8% 77.7%
26 MeTu3c (R) ACh 32 1.9 0.8% 78.4%
27 Mi15 (R) ACh 32 1.9 0.8% 79.2%
28 MeVPMe12 (L) ACh 30 1.8 0.7% 79.9%
29 Tm26 (R) ACh 25 1.5 0.6% 80.5%
30 MeVPMe11 (L) Glu 24 1.4 0.6% 81.1%
31 l-LNv (R) unclear 23 1.4 0.6% 81.7%
32 MeVP5 (R) unclear 23 1.4 0.6% 82.2%
33 Tm39 (R) ACh 23 1.4 0.6% 82.8%
34 aMe25 (R) unclear 19 1.1 0.5% 83.2%
35 SLP250 (R) unclear 19 1.1 0.5% 83.7%
36 Tm29 (R) Glu 18 1.1 0.4% 84.1%
37 aMe26 (R) ACh 17 1.0 0.4% 84.5%